Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SECUKINUMAB vs SELEGILINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SECUKINUMAB vs SELEGILINE: Safety Overview

Metric SECUKINUMAB SELEGILINE
Total FAERS Reports 151,223 932
Deaths Reported 6,855 36
Death Rate 4.5% 3.9%
Hospitalizations 19,098 199
Average Patient Age 52.3 yrs 58.7 yrs
% Female Patients 61.9% 57.4%
FDA Approval Date N/A Apr 1, 1997
Manufacturer Novartis Pharmaceuticals Corporation Bausch Health US, LLC
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Discontinued